9,171
Total Claims
$1.3M
Drug Cost
916
Beneficiaries
$1,455
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-5%
Cost per patient vs peers
$1,455 vs $1,524 avg
-21%
Brand preference vs peers
10.8% vs 13.7% avg
Brand vs Generic
89% generic
Brand: 988 claims · $1.1M
Generic: 8,183 claims · $184K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 396 | $500K |
| Rivaroxaban | 246 | $294K |
| Sacubitril/Valsartan | 140 | $227K |
| Evolocumab | 34 | $37K |
| Ticagrelor | 26 | $22K |
| Empagliflozin | 16 | $19K |
| Clopidogrel Bisulfate | 699 | $13K |
| Candesartan Cilexetil | 108 | $12K |
| Ranolazine | 50 | $12K |
| Atorvastatin Calcium | 990 | $11K |
| Evolocumab | 11 | $7,612 |
| Metoprolol Succinate | 394 | $7,407 |
| Diltiazem Hcl | 162 | $7,051 |
| Metoprolol Tartrate | 697 | $6,865 |
| Ezetimibe | 115 | $6,430 |
Prescribing Profile
61
Unique Drugs
$1.0M
Patient Profile
76
Avg Age
43%
Female
1.48
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data